Do urinary mast cell mediators predict immune response to BCG in patients with primary high-grade non-muscle invasive bladder cancer?
Yazar
Simsekoglu, Muhammed Fatih
Talat, Zubeyr
Erozenci, Ahmet
Uslu, Ezel
ÇİTGEZ, Sinharib
DEMİRDAĞ, Çetin
ÖNAL, Bülent
Kaleler, Islim
Üst veri
Tüm öğe kaydını gösterÖzet
Background Mast cells play a critical role in cancer-associated immunity. We aimed to determine the predictive value of urinary mast cell mediators in patients with non-muscle invasive bladder cancer (NMIBC) treated with Bacillus Calmette-Guerin (BCG) immunotherapy.
Koleksiyonlar
- Makale [92796]